Immediate revascularization of nonculprit lesions in patients with STEMI was not superior compared with deferred percutaneous coronary intervention of nonculprit lesions out to 3 years, researchers ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — The monthly rate of PCI for STEMI dropped steadily at the start of the COVID-19 pandemic and has yet ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) remains uncertain. A comparison of immediate percutaneous coronary ...

The risk of dying over the next decade for STEMI patients who survive the first 90 days after primary PCI is just a few percentage points higher than people in the general population, an observational ...

A new study from Denmark conducted over a 16-year period shows a 30% reduction in the 1-year mortality rate following percutaneous coronary intervention (PCI) for ST-segment elevation myocardial ...

For patients with STEMI secondary to spontaneous coronary artery dissection (SCAD), primary PCI can produce mortality and 30-day readmission rates similar to what’s seen in those treated for ...

BOSTON--(BUSINESS WIRE)--Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To-Unload (STEMI DTU) pilot trial data show significantly reduced infarct size in ...

ANN ARBOR, Michigan — The use of transradial PCI for the treatment of ST-segment elevation MI (STEMI) is on the rise in US clinical practice but still represents a very small percentage of overall PCI ...

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking ...